Accepted for Publication: July 20, 2011.
Author Contributions: Drs Carney, Tosti, Rich, and Elewski had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Carney, Tosti, Daniel, Scher, Rich, and Elewski. Acquisition of data: Carney, Tosti, Daniel, Scher, Rich, and Elewski. Analysis and interpretation of data: Tosti, Daniel, Scher, Rich, and DeCoster, and Elewski. Drafting of the manuscript: Carney, Tosti, Scher, Rich, and Elewski. Critical revision of the manuscript for important intellectual content: Carney, Tosti, Daniel, Scher, Rich, DeCoster, and Elewski. Statistical analysis: Tosti, Rich, DeCoster, and Elewski. Administrative, technical, and material support: Carney. Study supervision: Elewski.
Financial Disclosure: Dr Tosti reports receiving honoraria from Polychem and Vichy Laboratories. Dr Daniel reports serving as a consultant to Medicis Pharmaceutical Corp; receiving honoraria from Medicis Pharmaceutical Corp, Medimetrics, and Nycomed; and receiving royalties from Elsevier Inc. Dr Scher reports serving as a consultant to and receiving honoraria from Allergan Inc, Anacor Pharmaceuticals, Celtic Pharma, Dow Pharmaceutical Sciences, Galderma, NanoBio Corporation, NitricBio Therapeutics, Stiefel Laboratories Inc (a GSK company), Talima Therapeutics Inc, and Topica Pharmaceuticals Inc. Dr Rich reports receiving honoraria from Centocor Ortho Biotech Inc, Merck & Co, Inc, Stiefel Laboratories Inc, and Talima Therapeutics; and receiving grants from Abbott Laboratories, Amgen Inc, Basilea Pharmaceutica, Celgene Corp, Celtic Pharma, Centocor Ortho Biotech Inc, Cipher Pharmaceuticals Inc, Cytotech, Dow Pharmaceutical Sciences Inc, Galderma, Genetech Inc, GlaxoSmithKline, Intendis Inc, Merck & Co Inc, Merz Pharmaceuticals, Novartis, Novo Nordisk Inc, Novum Pharmaceutical Research Services, Nycomed, Oregan Aesthetic Technologies, Pfizer Inc, Shionogi & Co Ltd, Stiefel Laboratories Inc, Talima Therapeutics Inc, Tolmar Inc, and Topica Pharmaceuticals Inc. Dr Elewski reports receiving honoraria from Intendis Inc and Merck & Co Inc and receiving grants from Abbott Laboratories, Amgen Inc, Centocor Ortho Biotech Inc, Dow Pharmaceuticals Inc, Merck & Co Inc, NitricBio Therapeutics, Novartis, and Pfizer Inc. None of these disclosures is relevant to the study reported in this article.
Role of the Sponsor: The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Additional Contributions: The Alabama Dermatology Society standardized the OSI scoring sheet.